TRIS PHARMA, INC.

Lobbying client · New Jersey · filed 2025 to 2025

Biopharmaceutical company

$270,000 Reported spend

3 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 3 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (66611), not by name.

Firms hired 1

VENN STRATEGIES $270,000 3 filings

Reported by year 1 year

2025 $270,000 3 filings

Issues lobbied 1

Health Issues 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 4 total

3T

VENN STRATEGIES

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $70,000 income · posted Oct 20, 2025

View → Q3

VENN STRATEGIES Amended

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $70,000 income · posted Oct 20, 2025

View → Q2

VENN STRATEGIES

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $200,000 income · posted Jul 18, 2025

View → RR

VENN STRATEGIES

2nd Quarter (Apr 1 - June 30) 2025 · posted May 15, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.